Is Apollo Hospitals overvalued or undervalued?

Oct 29 2025 08:04 AM IST
share
Share Via
As of October 28, 2025, Apollo Hospitals is fairly valued with a PE ratio of 72.19 and an EV to EBITDA of 37.10, showing a strong return of 14.06% over the past year, although it underperformed compared to the Sensex's 5.78% return.
As of 28 October 2025, Apollo Hospitals has moved from an attractive to a fair valuation grade. The company appears to be fairly valued based on its current metrics. Key ratios include a PE ratio of 72.19, an EV to EBITDA of 37.10, and a ROE of 17.61%.
When compared to peers, Apollo Hospitals' PE ratio is lower than Max Healthcare's 95.25 and Fortis Health's 86.69, both of which are considered very expensive. However, it still indicates a premium valuation within the sector. Notably, while Apollo Hospitals has shown a strong return of 14.06% over the past year, it has underperformed slightly compared to the Sensex, which returned 5.78% in the same period. Overall, Apollo Hospitals is fairly valued in the current market context.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News